{"url_path":"/sec/ocgn/8-k/2026-05-14/item-5-02","section_key":"item-5-02","section_title":"Item 5.02 Departure of Directors or Certain Officers; Election","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1372299/0001104659-26-061241-index.html","accession_number":"0001104659-26-061241","cik":"0001372299","ticker":"OCGN","issuer_name":"Ocugen, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1372299/0001104659-26-061241-index.html","primary_entity_key":"0001372299","primary_entity_name":"Ocugen, Inc."},"word_count":40,"has_tables":true,"body_markdown":"**Item 5.02. Departure of Directors or Certain Officers; Election\nof Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.**\n\n \n\nEffective May 8, 2026, Huma Qamar, M.D., MPH, CMI, separated from\nOcugen, Inc. (the “Company”) as its Chief Medical Officer."}